RxDoctor Payments DataLook up a doctor →

Sujatha Nallapareddy, MD

Hematology & Oncology · Aurora, CONPI 1164578779

Payments from drug & device makers

$1,707,319in general payments, 2019–2025

Across 586 payments — averaging $2913.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Seagen Inc.$953K
  • Bayer$172K
  • Mirati Therapeutics, Inc.$159K
  • Pfizer$144K
  • Merck$77K
  • Jazz Pharmaceuticals Inc.$56K
  • plus $147K from 36 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Seagen Inc.191$952,984
Bayer40$171,678
Mirati Therapeutics, Inc.31$158,838
Pfizer36$144,315
Merck18$77,260
Jazz Pharmaceuticals Inc.28$55,583
Takeda Pharmaceuticals U.S.A., Inc.36$37,104
Genentech, Inc.3$24,553
AstraZeneca28$19,306
Amgen4$12,399
Ipsen Biopharmaceuticals, Inc10$10,063
Lilly USA, LLC3$9,225
Array Biopharma Inc9$8,011
Novartis7$5,417
Exelixis Inc.26$3,884
Sanofi2$2,844
Daiichi Sankyo Inc.15$2,729
Fresenius Kabi USA, LLC1$2,250
Astellas Pharma US Inc6$2,142
E.r. Squibb & Sons, L.L.C.11$2,090
Regeneron Healthcare Solutions, Inc.3$1,531
Taiho Oncology, Inc.2$1,114
Tersera Therapeutics LLC17$443
Genmab U.S., Inc.10$305
GSK7$261
Gilead10$238
Eisai Inc.6$129
AbbVie5$98
CTI Biopharma Corp.3$74
Rigel Pharmaceuticals, Inc.1$69
Genentech USA, Inc.3$55
Bristol Myers Squibb2$55
Histosonics, Inc.1$37
Boehringer Ingelheim2$36
Eli Lilly1$35
Caris MPI, Inc.1$29
Alnylam Pharmaceuticals Inc.1$27
Sobi, Inc1$26
Pharmacosmos Therapeutics Inc.1$21
Clovis Oncology, Inc.2$20
Myriad Genetic Laboratories, Inc.1$20
Novocure Inc.1$20

How this compares

$1,707,319 in reported general payments places this provider in the 80th percentile of 169 hematology & oncology providers in Colorado.

See all hematology & oncology providers in Colorado →

Medicare billing

Part B allowed, 2024
$5,612,805
Medicare patients
981
Services billed
247,176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Aurora

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →